Pharming Group N Vis A Biopharmaceutical Company Based In Leidenthe Netherlandsestablished In 1988The Company Specializes In Developing And Commercializing Innovative Protein Replacement Therapies And Precision Medicines Aimed At Treating Rare And Life Threatening Diseasespharming Is Publicly Traded On Both The Nasdaq And The Amsterdam Stock Exchange The Companyae S Product Portfolio Includes Ruconesta Treatment For Acute Hereditary Angioedemaand Joenjaan Oral Medication For Activated Phosphoinositide 3 Kinase Delta Syndromepharming Is Also Developing Otl 105An Investigational Gene Therapy For Hereditary Angioedemain Collaboration With Orchard Therapeuticswith Approximately 426 Employeespharming Is Actively Engaged In Over 40 Clinical Trialsfocusing On Advancing Treatments For Various Rare Diseases And Addressing Unmet Medical Needs
No conferences found for this company.
| Company Name | Pharming Technologies Bv |
| Country |
Netherlands
|
| Address | N/A |
| Telephone | N/A |
| N/A |
